Press "Enter" to skip to content

New patent for Chiesi drug FERRIPROX

0
Copyright © DrugPatentWatch. Originally published at New patent for Chiesi drug FERRIPROX

Annual Drug Patent Expirations for FERRIPROX
Annual Drug Patent Expirations for FERRIPROX

Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for FERRIPROX.

This drug has forty-nine patent family members in twenty-eight countries.

The generic ingredient in FERRIPROX is deferiprone. Two suppliers are listed for this compound. Additional details are available on the deferiprone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Chiesi drug FERRIPROX
    Online Certificate Course

    Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

    • When will key drug patents expire?
    • How can I find, evaluate, and plan for generic market entry opportunities?
    • How can I find proprietary out-of-court settlements and deal terms?
    DrugPatentWatch - Make Better Decisions